Ting Shi
About
Ting Shi is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Ting Shi has authored 93 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 22 papers in Infectious Diseases and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ting Shi's work include Respiratory viral infections research (26 papers), Pneumonia and Respiratory Infections (15 papers) and COVID-19 Clinical Research Studies (13 papers). Ting Shi is often cited by papers focused on Respiratory viral infections research (26 papers), Pneumonia and Respiratory Infections (15 papers) and COVID-19 Clinical Research Studies (13 papers). Ting Shi collaborates with scholars based in United Kingdom, China and United States. Ting Shi's co-authors include Harish Nair, Harry Campbell, John Burrows, Kenneth A McLean, Miloje Savic, Angela R Branche, Jean‐Yves Pirçon, Yolanda Penders, Evelyn Balsells and Igor Rudan and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Stroke.
In The Last Decade
Ting Shi
81 papers receiving 2.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ting Shi United Kingdom | 22 | 1.3k | 621 | 547 | 241 | 215 | 93 | 2.4k | ||
| Job B. M. van Woensel Netherlands | 32 | 1.2k 0.9× | 567 0.9× | 1.1k 2.0× | 202 0.8× | 290 1.3× | 133 | 2.6k | ||
| Massimiliano Raponi Italy | 25 | 938 0.7× | 312 0.5× | 302 0.6× | 136 0.6× | 267 1.2× | 154 | 2.1k | ||
| Éric Batard France | 24 | 585 0.5× | 631 1.0× | 406 0.7× | 905 3.8× | 259 1.2× | 102 | 2.7k | ||
| David R. Murdoch New Zealand | 17 | 1.1k 0.9× | 341 0.5× | 274 0.5× | 152 0.6× | 100 0.5× | 24 | 1.9k | ||
| Muralidharan Jayashree India | 25 | 623 0.5× | 565 0.9× | 428 0.8× | 112 0.5× | 287 1.3× | 201 | 2.3k | ||
| Clark D Russell United Kingdom | 17 | 929 0.7× | 1.6k 2.6× | 380 0.7× | 281 1.2× | 245 1.1× | 43 | 3.0k | ||
| Pingsheng Wu United States | 33 | 1.3k 1.0× | 458 0.7× | 1.1k 2.0× | 302 1.3× | 422 2.0× | 110 | 3.3k | ||
| Daniel Faurholt‐Jepsen Denmark | 23 | 672 0.5× | 796 1.3× | 176 0.3× | 158 0.7× | 379 1.8× | 127 | 1.7k | ||
| Gregorio P. Milani Italy | 28 | 512 0.4× | 403 0.6× | 600 1.1× | 244 1.0× | 450 2.1× | 236 | 2.7k | ||
| Ji Ye Jung South Korea | 34 | 1.1k 0.8× | 651 1.0× | 1.6k 3.0× | 540 2.2× | 584 2.7× | 243 | 4.2k |
Countries citing papers authored by Ting Shi
Since
Specialization
Citations
This map shows the geographic impact of Ting Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting Shi more than expected).
Fields of papers citing papers by Ting Shi
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ting Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting Shi. The network helps show where Ting Shi may publish in the future.
Co-authorship network of co-authors of Ting Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Ting Shi. A scholar is included among the top collaborators of Ting Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting Shi. Ting Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Gibbons, Cheryl, Ting Shi, Christopher Sullivan, et al.. (2025). RSV Vaccination Programme for Older Adults: A Scotland-Wide Study on RSVpreF Vaccine Safety. Vaccines. 13(11). 1088–1088.
2.
Kibuchi, Eliud, Evangelia Demou, Alastair H. Leyland, et al.. (2025). Are ethnic inequalities in COVID-19 outcomes mediated by occupation risk? Analyses of a 2-year record linked national cohort study in Scotland. European Journal of Public Health. 35(2). 379–385.
3.
Moore, Elizabeth, Tracy Jackson, Ting Shi, et al.. (2025). Mapping Use of High Dose or Long‐Term Oral Glucocorticoids and Steroid‐Sparing Strategies in Adults With Chronic Conditions: A Rapid Scoping Review of Reviews. Pharmacoepidemiology and Drug Safety. 34(10). e70233–e70233.
4.
Gao, Junyi, Liantao Ma, John Busby, et al.. (2025). Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysis. EClinicalMedicine. 84. 103281–103281.
5.
Pei, Ruonan, Thomas Williams, Jennifer K Quint, et al.. (2025). Real-world effectiveness and safety of nirsevimab, RSV maternal vaccine and RSV vaccines for older adults: a living systematic review and meta-analysis. Thorax. 80(11). 838–848.
6.
McQueenie, Ross, Safraj Shahul Hameed, Cheryl Gibbons, et al.. (2025). Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case–control study and cohort analysis. The Lancet Infectious Diseases. 26(4). 362–373.
7.
Shi, Ting, Wen‐Jia Yang, Hao Ouyang, et al.. (2024). Biological characterization and in vitro fungicide screening of a new causal agent of walnut leaf spot in Guizhou Province, China. Frontiers in Microbiology. 15. 1439487–1439487.
8.
Zhang, Xuewei, et al.. (2024). Review of ultrasonic vibration-assisted milling technology. Precision Engineering. 91. 601–616.
9.
Ward, Isobel, Chris Robertson, Lynsey Patterson, et al.. (2024). Risk of COVID-19 death in adults who received booster COVID-19 vaccinations in England. Nature Communications. 15(1). 398–398.
10.
Shi, Ting, et al.. (2024). Indolo[3,2-c]isoquinoline Hydroxamic Acid Derivatives as Novel Orally Topoisomerase-Histone Deacetylase Dual Inhibitors for NSCLC Therapy. Journal of Medicinal Chemistry. 68(2). 1300–1315.
11.
Chan, Mei, Nan Hu, Brendan McMullan, et al.. (2024). Clinical Characteristics and In-hospital Outcomes Associated With Respiratory Syncytial Virus vs Other Viral Acute Lower Respiratory Infections in Hospitalized Children Younger Than 2 Years. The Journal of Infectious Diseases. 231(5). 1309–1317.
12.
Savic, Miloje, Yolanda Penders, Ting Shi, Angela R Branche, & Jean‐Yves Pirçon. (2022). Respiratory syncytial virus disease burden in adults aged 60 years and older in high‐income countries: A systematic literature review and meta‐analysis. Influenza and Other Respiratory Viruses. 17(1). e13031–e13031.
13.
Mulholland, Rachel, Utkarsh Agrawal, Helen Bedford, et al.. (2022). Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic: An observational study of routinely collected data. PLoS Medicine. 19(2). e1003916–e1003916.
14.
Shi, Ting, Wei Shan, Qinghui Chen, et al.. (2022). Hospitalization rate of respiratory syncytial virus‐associated acute lower respiratory infection among young children in Suzhou, China, 2010–2014. Influenza and Other Respiratory Viruses. 16(4). 789–799.
15.
Daines, Luke, Rachel Mulholland, Eleftheria Vasileiou, et al.. (2022). Deriving and validating a risk prediction model for long COVID-19: protocol for an observational cohort study using linked Scottish data. BMJ Open. 12(7). e059385–e059385.
16.
Mueller, Tanja, Steven Kerr, Stuart McTaggart, et al.. (2021). Retrospective cohort study to evaluate medication use in patients hospitalised with COVID-19 in Scotland: protocol for a national observational study. BMJ Open. 11(11). e054861–e054861.
17.
Bradley, Declan, Siobhán Murphy, Stephanie Arnold, et al.. (2021). Investigating the association between COVID-19 vaccination and care home outbreak frequency and duration. Public Health. 203. 110–115.
18.
Shi, Ting, Laura Denney, Huazhang An, Ling‐Pei Ho, & Yuejuan Zheng. (2020). Alveolar and lung interstitial macrophages: Definitions, functions, and roles in lung fibrosis. Journal of Leukocyte Biology. 110(1). 107–114.
19.
Shi, Ting, Kenneth A McLean, Harry Campbell, & Harish Nair. (2015). Aetiological role of common respiratory viruses in acute lower respiratory infections in children under five years: A systematic review and meta–analysis. Journal of Global Health. 5(1).
20.
Shi, Ting, Evelyn Balsells, Elizabeth Wastnedge, et al.. (2015). Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta–analysis. SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Job B. M. van Woensel Breakdown of academic impact, for papers by Massimiliano Raponi Breakdown of academic impact, for papers by Éric Batard Breakdown of academic impact, for papers by David R. Murdoch Breakdown of academic impact, for papers by Muralidharan Jayashree Breakdown of academic impact, for papers by Clark D Russell Breakdown of academic impact, for papers by Pingsheng Wu Breakdown of academic impact, for papers by Daniel Faurholt‐Jepsen Breakdown of academic impact, for papers by Gregorio P. Milani Breakdown of academic impact, for papers by Ji Ye Jung